Brainsway Ltd. has reported positive results in a safety and efficacy trial of its non-invasive proprietary coil to stimulate the motor cortex for the lower limbs in patients with advanced multiple sclerosis.
The double blind trial was conducted by Technologies Innovation Distribution SrL on 23 patients at INSPE Medical Center in Milan. Half the patients were treated by the device over three weeks, and half received a placebo.
Success was measured as the ability to walk ten meters in six minutes, a standard measurement under the Modified Ashworth Scale (MAS). The patients who received the treatment showed a clear statistical improvement compared with the patients who received the placebo. No side effects were recorded.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1430